NCT00359840View on ClinicalTrials.gov

A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

September 30, 2007

Conditions

Anemia

Interventions

DRUG

darbepoetin alfa

Trial Locations (8)

Unknown

Tokai region, Aichi

Shikoku region, Ehime

Kyusyu region, Fukuoka, Kumamoto

Hokkaido region, Hokkaido

Kinki region, Kyoto, Osaka, Nara

Tohoku region, Miyagi

Hokuriku region, Niigata, Ishikawa

Kanto region, Tochigi, Saitama, Tokyo, Kanagawa

All Listed Sponsors

lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT00359840 - A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor | Biotech Hunter | Biotech Hunter